You are here: Industry Insights > Merck

News List

Belén Garijo appointed as Deputy CEO of Merck expresspharma
July 15, 2020
Belén Garijo has also been appointed as the vice chairman of the company's executive board.
EU secures potential COVID-19 drugs from Roche, Germany’s Merck – source expresspharma
July 10, 2020
The deals cover Roche’s arthritis drug RoActemra and Merck’s multiple sclerosis drug Rebif - both seen as potential COVID-19 therapies - and will secure supplies for any of the 27 European Union member states wanting to buy them.
US FDA declines to approve Merck and Eisai’s liver cancer combo therapy expresspharma
July 10, 2020
The FDA's complete response letter cited lack of sufficient evidence that the Keytruda-Lenvima combination therapy had a meaningful advantage over available treatments for the condition.
Merck Inks $425M Oncology Deal with Foghorn Therapeutics contractpharma
July 09, 2020
To discover and develop novel oncology therapeutics against transcription factor target.
Merck initiates first clinical trial of TLR7 and 8 inhibitor as a potential treatment for severe symptoms of COVID-19 infection worldpharmanews
July 06, 2020
Merck, a leading science and technology company, announced the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug application (IND) for M5049 for the treatment of patients with Covid-19 pneumonia.
Linnaeus Announces Clinical Trial Collaboration Agreement with Merck americanpharmaceuticalreview
July 03, 2020
Linnaeus Therapeutics has entered into a clinical collaboration agreement with Merck to evaluate the combination of its lead investigational product candidate LNS8801, and Merck's anti-PD-1 therapy ...
Yumanity Therapeutics signs drug development deal with Merck pharmaceutical-technology
June 28, 2020
US-based Yumanity Therapeutics has signed a research collaboration and licence agreement with Merck (MSD) to develop new therapies for neurodegenerative diseases.
EMA to consider expanding use of Merck/Pfizer's Bavencio pharmatimes
June 23, 2020
The European Medicines Agency has validated for review Merck and Pfizer's application to market Bavencio (avelumab) for first-line maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma (UC).
Merck and Pfizer’s SGLT2 inhibitor STEGLATRO meets primary endpoint in VERTIS CV trial pharmaceutical-business-review
June 18, 2020
Merck, known as MSD outside the United States and Canada, and Pfizer Inc., announced the presentation of results from the Phase 3 VERTIS CV cardiovascular (CV) outcomes trial that evaluated STEGLATRO (ertugliflozin) ...
PeptiDream and Merck partner to develop Covid-19 therapeutics pharmaceutical-technology
June 15, 2020
Japanese biopharmaceutical firm PeptiDream has partnered with Merck (MSD) to discover and develop new peptide therapeutics which could neutralise SARS-CoV-2, the novel coronavirus that causes Covid-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page